مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

127
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

112
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

The Impact of CRISPR-Cas System on Antiviral Therapy

Pages

  591-597

Abstract

 Clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein nuclease (Cas) is identified as an adaptive immune system in archaea and bacteria. Type II of this system, CRISPR-Cas9, is the most versatile form that has enabled facile and efficient targeted Genome editing. Viral infections have serious impacts on global health and conventional antiviral therapies have not yielded a successful solution hitherto. The CRISPR-Cas9 system represents a promising tool for eliminating viral infections. In this review, we highlight 1) the recent progress of CRISPR-Cas technology in decoding and diagnosis of viral outbreaks, 2) its applications to eliminate viral infections in both pre-integration and provirus stages, and 3) various Delivery systems that are employed to introduce the platform into target cells.

Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    NADERI, FATEMEH, Hayat Khan, Amjad, MEMARNEJADIAN, ARASH, & RAHIMPOUR, AZAM. (2018). The Impact of CRISPR-Cas System on Antiviral Therapy. ADVANCED PHARMACEUTICAL BULLETIN, 8(4), 591-597. SID. https://sid.ir/paper/756243/en

    Vancouver: Copy

    NADERI FATEMEH, Hayat Khan Amjad, MEMARNEJADIAN ARASH, RAHIMPOUR AZAM. The Impact of CRISPR-Cas System on Antiviral Therapy. ADVANCED PHARMACEUTICAL BULLETIN[Internet]. 2018;8(4):591-597. Available from: https://sid.ir/paper/756243/en

    IEEE: Copy

    FATEMEH NADERI, Amjad Hayat Khan, ARASH MEMARNEJADIAN, and AZAM RAHIMPOUR, “The Impact of CRISPR-Cas System on Antiviral Therapy,” ADVANCED PHARMACEUTICAL BULLETIN, vol. 8, no. 4, pp. 591–597, 2018, [Online]. Available: https://sid.ir/paper/756243/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button